Understanding melioidosis: Review
ECFMG-certified International Medical Graduate and Clinical Assistant, Hamtramck, USA.
Review
World Journal of Biology Pharmacy and Health Sciences, 2024, 20(01), 113–115.
Article DOI: 10.30574/wjbphs.2024.20.1.0721
Publication history:
Received on 22 August 2024; revised on 02 October 2024; accepted on 04 October 2024
Abstract:
Melioidosis is an infectious disease caused by the Gram-negative intracellular bacterium Burkholderia pseudomallei, first identified in 1911. While it is predominantly reported in Southeast Asia, cases have also emerged in other regions, including parts of the United States. The clinical presentation of melioidosis often mimics that of tuberculosis and influenza, leading to diagnostic confusion that can delay appropriate treatment. This delay is particularly concerning, as timely diagnosis and intervention are critical to prevent severe complications, including septicemia and potential death. Education about this disease and taking preventive measures play a crucial role in managing this disease. The possibility of using the causative bacterium as a biological weapon poses a serious threat to public health.
Keywords:
Melioidosis; Burkholderia pseudomallei, Signs and symptoms of melioidosis; Diagnosis of and treatment of melioidosis; Vaccination against melioidosis; Burkholderia pseudomallei as bio-weapon
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0